BACKGROUND: Excess deaths have occurred among pregnant women during influenza pandemics, but the impact of influenza during nonpandemic years is unclear. We evaluated the impact of exposure during nonpandemic influenza seasons on the rates of hospital admissions and physician visits because of respiratory illness among pregnant women. METHODS: We conducted a 13-year (1990-2002) population-based cohort study involving pregnant women in Nova Scotia. We compared rates of hospital admissions and physician office visits because of respiratory illness during the influenza season in each trimester of pregnancy with rates during the influenza season in the year before pregnancy and with rates in non-influenza seasons. Poisson regression analyses were performed to estimate rate ratios and 95% confidence intervals (CIs). RESULTS: Of 134,188 pregnant women in the study cohort, 510 (0.4%) were admitted to hospital because of a respiratory illness during pregnancy and 33,775 (25.2%) visited their physician for the same reason during pregnancy. During the influenza seasons, the rate ratio of hospital admissions in the third trimester compared with admissions in the year before pregnancy was 7.9 (95% CI 5.0-12.5) among women with comorbidities and 5.1 (95% CI 3.6-7.3) among those without comorbidities. The rate of hospital admissions in the third trimester among women without comorbidities was 7.4 per 10,000 woman-months during the influenza season, compared with 5.4 and 3.1 per 10,000 woman-months during the peri-and non-influenza seasons respectively. Corresponding rates among women with comorbidities were 44.9, 9.3 and 18.9 per 10,000 woman-months. Only 6.7% of women with comorbidities had received influenza immunization. INTERPRETATION: Our data support the recommendation that pregnant women with comorbidities should receive influenza vaccination regardless of their stage of pregnancy during the influenza season. Since hospital admissions because of respiratory illness during the influenza season were also increased among pregnant women without comorbidities, all pregnant women are likely to benefit from influenza vaccination.
BACKGROUND:Excess deaths have occurred among pregnant women during influenza pandemics, but the impact of influenza during nonpandemic years is unclear. We evaluated the impact of exposure during nonpandemic influenza seasons on the rates of hospital admissions and physician visits because of respiratory illness among pregnant women. METHODS: We conducted a 13-year (1990-2002) population-based cohort study involving pregnant women in Nova Scotia. We compared rates of hospital admissions and physician office visits because of respiratory illness during the influenza season in each trimester of pregnancy with rates during the influenza season in the year before pregnancy and with rates in non-influenza seasons. Poisson regression analyses were performed to estimate rate ratios and 95% confidence intervals (CIs). RESULTS: Of 134,188 pregnant women in the study cohort, 510 (0.4%) were admitted to hospital because of a respiratory illness during pregnancy and 33,775 (25.2%) visited their physician for the same reason during pregnancy. During the influenza seasons, the rate ratio of hospital admissions in the third trimester compared with admissions in the year before pregnancy was 7.9 (95% CI 5.0-12.5) among women with comorbidities and 5.1 (95% CI 3.6-7.3) among those without comorbidities. The rate of hospital admissions in the third trimester among women without comorbidities was 7.4 per 10,000 woman-months during the influenza season, compared with 5.4 and 3.1 per 10,000 woman-months during the peri-and non-influenza seasons respectively. Corresponding rates among women with comorbidities were 44.9, 9.3 and 18.9 per 10,000 woman-months. Only 6.7% of women with comorbidities had received influenza immunization. INTERPRETATION: Our data support the recommendation that pregnant women with comorbidities should receive influenza vaccination regardless of their stage of pregnancy during the influenza season. Since hospital admissions because of respiratory illness during the influenza season were also increased among pregnant women without comorbidities, all pregnant women are likely to benefit from influenza vaccination.
Authors: Flor M Munoz; Anthony J Greisinger; Oscar A Wehmanen; Melanie E Mouzoon; James C Hoyle; Frances A Smith; W Paul Glezen Journal: Am J Obstet Gynecol Date: 2005-04 Impact factor: 8.661
Authors: Germaine Buck Louis; Vanja Dukic; Patrick J Heagerty; Thomas A Louis; Coutney D Lynch; Louise M Ryan; Enrique F Schisterman; Ann Trumble Journal: Stat Methods Med Res Date: 2006-04 Impact factor: 3.021
Authors: Marie R Griffin; Frances J Walker; Marika K Iwane; Geoffrey A Weinberg; Mary Allen Staat; Dean D Erdman Journal: Pediatr Infect Dis J Date: 2004-11 Impact factor: 2.129
Authors: Kevin T Shiley; Gregory Nadolski; Timothy Mickus; Neil O Fishman; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2010-07 Impact factor: 3.254
Authors: Beth A Halperin; Donna MacKinnon-Cameron; Shelly McNeil; Jennifer Kalil; Scott A Halperin Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452
Authors: Katherine A Poehling; Peter G Szilagyi; Mary A Staat; Beverly M Snively; Daniel C Payne; Carolyn B Bridges; Susan Y Chu; Laney S Light; Mila M Prill; Lyn Finelli; Marie R Griffin; Kathryn M Edwards Journal: Am J Obstet Gynecol Date: 2011-02-23 Impact factor: 8.661